Ownership history in WOLVERINE TRADING, LLC · 42 quarters on record
This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in SUPERNUS PHARMACEUTICALS INC (SUPN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | REDUCED | 7,000 | -6,000 | -46.2% | 0.00% | $218K | $31.52 |
| 2022 Q1 | ADDED | 13,000 | +3,100 | +31.3% | 0.00% | $421K | $32.32 |
| 2021 Q4 | ADDED | 9,900 | +3,200 | +47.8% | 0.00% | $297K | $29.16 |
| 2021 Q2 | REDUCED | 6,700 | -1,200 | -15.2% | 0.00% | $212K | $30.79 |
| 2021 Q1 | ADDED | 7,900 | +259 | +3.4% | 0.00% | $207K | $26.18 |
| 2021 Q1 | REDUCED | 7,641 | -16,059 | -67.8% | 0.00% | $200K | $26.18 |
| 2021 Q1 | ADDED | 23,700 | +5,800 | +32.4% | 0.00% | $620K | $26.18 |
| 2020 Q1 | ADDED | 17,900 | +5,200 | +40.9% | 0.00% | $307K | $17.99 |
| 2020 Q1 | REDUCED | 12,700 | -22,600 | -64.0% | 0.00% | $218K | $17.99 |
| 2019 Q4 | ADDED | 35,300 | +7,600 | +27.4% | 0.00% | $824K | $23.72 |
As of 2025 Q4 — sorted by position size